141 related articles for article (PubMed ID: 26859826)
1. High Plasma Concentrations of Zidovudine (AZT) Do Not Parallel Intracellular Concentrations of AZT-Triphosphates in Infants During Prevention of Mother-to-Child HIV-1 Transmission.
Kinai E; Kato S; Hosokawa S; Sadatsuki M; Gatanaga H; Kikuchi Y; Lam NV; Ha do Q; Kinh NV; Liem NT; Oka S
J Acquir Immune Defic Syndr; 2016 Jul; 72(3):246-53. PubMed ID: 26859826
[TBL] [Abstract][Full Text] [Related]
2. High levels of zidovudine (AZT) and its intracellular phosphate metabolites in AZT- and AZT-lamivudine-treated newborns of human immunodeficiency virus-infected mothers.
Durand-Gasselin L; Pruvost A; Dehée A; Vaudre G; Tabone MD; Grassi J; Leverger G; Garbarg-Chenon A; Bénech H; Dollfus C
Antimicrob Agents Chemother; 2008 Jul; 52(7):2555-63. PubMed ID: 18426897
[TBL] [Abstract][Full Text] [Related]
3. Ultrasensitive method to quantify intracellular zidovudine mono-, di- and triphosphate concentrations in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
Kinai E; Gatanaga H; Kikuchi Y; Oka S; Kato S
J Mass Spectrom; 2015 Jun; 50(6):783-91. PubMed ID: 26169132
[TBL] [Abstract][Full Text] [Related]
4. Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants.
Rodman JH; Flynn PM; Robbins B; Jimenez E; Bardeguez AD; Rodriguez JF; Blanchard S; Fridland A
J Infect Dis; 1999 Dec; 180(6):1844-50. PubMed ID: 10558940
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells.
Dumond JB; Yang KH; Kendrick R; Reddy YS; Kashuba AD; Troiani L; Bridges AS; Fiscus SA; Forrest A; Cohen MS
Antimicrob Agents Chemother; 2015 Oct; 59(10):6395-401. PubMed ID: 26239974
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of zidovudine into cord blood DNA of infants and peripheral blood DNA of their HIV-1-positive mothers.
Olivero OA; Shearer GM; Chougnet CA; Kovacs AA; Baker R; Stek AM; Khoury MM; Poirier MC
Ann N Y Acad Sci; 2000 Nov; 918():262-8. PubMed ID: 11131712
[TBL] [Abstract][Full Text] [Related]
7. Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study.
Chen J; Flexner C; Liberman RG; Skipper PL; Louissaint NA; Tannenbaum SR; Hendrix CW; Fuchs EJ
J Acquir Immune Defic Syndr; 2012 Dec; 61(5):593-9. PubMed ID: 23187888
[TBL] [Abstract][Full Text] [Related]
8. Hematological changes in women and infants exposed to an AZT-containing regimen for prevention of mother-to-child-transmission of HIV in Tanzania.
Ziske J; Kunz A; Sewangi J; Lau I; Dugange F; Hauser A; Kirschner W; Harms G; Theuring S
PLoS One; 2013; 8(2):e55633. PubMed ID: 23405185
[TBL] [Abstract][Full Text] [Related]
9. A sensitive nonisotopic method for the determination of intracellular azidothymidine 5'-mono-, 5'-di-, and 5'-triphosphate.
Toyoshima T; Kimura S; Muramatsu S; Takahagi H; Shimada K
Anal Biochem; 1991 Aug; 196(2):302-7. PubMed ID: 1776679
[TBL] [Abstract][Full Text] [Related]
10. Improved method to quantify intracellular zidovudine mono- and triphosphate in peripheral blood mononuclear cells by liquid chromatography-tandem mass spectrometry.
Compain S; Durand-Gasselin L; Grassi J; Benech H
J Mass Spectrom; 2007 Mar; 42(3):389-404. PubMed ID: 17238240
[TBL] [Abstract][Full Text] [Related]
11. A method for the quantification of intracellular zidovudine nucleotides.
Kuster H; Vogt M; Joos B; Nadai V; Lüthy R
J Infect Dis; 1991 Oct; 164(4):773-6. PubMed ID: 1894938
[TBL] [Abstract][Full Text] [Related]
12. Joint population pharmacokinetic analysis of zidovudine, lamivudine, and their active intracellular metabolites in HIV patients.
Bazzoli C; Bénech H; Rey E; Retout S; Salmon D; Duval X; Tréluyer JM; Mentré F;
Antimicrob Agents Chemother; 2011 Jul; 55(7):3423-31. PubMed ID: 21576446
[TBL] [Abstract][Full Text] [Related]
13. Development of a direct assay for measuring intracellular AZT triphosphate in humans peripheral blood mononuclear cells.
Becher F; Schlemmer D; Pruvost A; Nevers MC; Goujard C; Jorajuria S; Guerreiro C; Brossette T; Lebeau L; Créminon C; Grassi J; Benech H
Anal Chem; 2002 Aug; 74(16):4220-7. PubMed ID: 12199596
[TBL] [Abstract][Full Text] [Related]
14. Determination of zidovudine triphosphate intracellular concentrations in peripheral blood mononuclear cells from human immunodeficiency virus-infected individuals by tandem mass spectrometry.
Font E; Rosario O; Santana J; García H; Sommadossi JP; Rodriguez JF
Antimicrob Agents Chemother; 1999 Dec; 43(12):2964-8. PubMed ID: 10582890
[TBL] [Abstract][Full Text] [Related]
15. Maternal immune responses and risk of infant infection with HIV-1 after a short course Zidovudine in a cohort of HIV-1 infected pregnant women in rural Kenya.
Makokha EP; Songok EM; Orago AA; Koech DK; Chemtai AK; Kobayashi N; Mpoke S; Tukei PM; Andayi FA; Lihana RW; Adungo NI; Vulule JM
East Afr Med J; 2002 Nov; 79(11):567-73. PubMed ID: 12630488
[TBL] [Abstract][Full Text] [Related]
16. Plasma and cellular markers of 3'-azido-3'-dideoxythymidine (AZT) metabolism as indicators of DNA damage in cord blood mononuclear cells from infants receiving prepartum NRTIs.
Meng Q; Olivero OA; Fasco MJ; Bellisario R; Kaminsky L; Pass KA; Wade NA; Abrams EJ; Nesel CJ; Ness RB; Bigbee WL; O'Neill JP; Walker DM; Poirier MC; Walker VE
Environ Mol Mutagen; 2007; 48(3-4):307-21. PubMed ID: 17358024
[TBL] [Abstract][Full Text] [Related]
17. Short course of AZT halves HIV-1 perinatal transmission.
Morris K
Lancet; 1998 Feb; 351(9103):651. PubMed ID: 9500334
[TBL] [Abstract][Full Text] [Related]
18. Triple antiretroviral compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial.
; de Vincenzi I
Lancet Infect Dis; 2011 Mar; 11(3):171-80. PubMed ID: 21237718
[TBL] [Abstract][Full Text] [Related]
19. Intracellular nucleoside triphosphate concentrations in HIV-infected patients on dual nucleoside reverse transcriptase inhibitor therapy.
Moore JD; Acosta EP; Johnson VA; Bassett R; Eron JJ; Fischl MA; Long MC; Kuritzkes DR; Sommadossi JP
Antivir Ther; 2007; 12(6):981-6. PubMed ID: 17926654
[TBL] [Abstract][Full Text] [Related]
20. The effect of zidovudine dose on the formation of intracellular phosphorylated metabolites.
Barry MG; Khoo SH; Veal GJ; Hoggard PG; Gibbons SE; Wilkins EG; Williams O; Breckenridge AM; Back DJ
AIDS; 1996 Oct; 10(12):1361-7. PubMed ID: 8902065
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
